The leading open access journal in the field of neurosciences, Molecular Neurodegeneration encompasses all aspects of neurodegeneration research at the molecular and cellular levels.
Looking for answers far away from the soma—the (un)known axonal functions of TDP-43, and their contribution to early NMJ disruption in ALS
Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
BACE1 regulates expression of Clusterin in astrocytes for enhancing clearance of β-amyloid peptides
Opinion: more mouse models and more translation needed for ALS
The neuropathological diagnosis of Alzheimer’s disease
Pineal gland dysfunction in Alzheimer’s disease: relationship with the immune-pineal axis, sleep disturbance, and neurogenesis
The SH-SY5Y cell line in Parkinson’s disease research: a systematic review
The Alzheimer's disease β-secretase enzyme, BACE1
Drosophila melanogaster as a model organism for Alzheimer’s disease
Glial and Vascular Contributions to Neurodegenerative Diseases
See Molecular Neurodegeneration's ongoing Collection on Glial and Vascular Contributions to Neurodegenerative Diseases.
ALS: Challenges and New Advances
See Molecular Neurodegeneration's ongoing Collection on ALS: Challenges and New Advances.
ISMND Science Webinar Series
ISMND invites you to join their upcoming webinar! Click the link below to register.
When: Wednesday, May 31 from 10 AM - 11 AM (EST)
Topic: The neuropathology of Alzheimer's disease: What do biomarkers recognize and what cannot be detected during life?
Presented By: Professor of Neuropathology at KU Leuven, Dr. Dietmar Thal, MD, PhD
News from Alzforum
Annual Journal Metrics
18.897 - 2-year Impact Factor (2021)
15.021 - 5-year Impact Factor (2021)
2.702 - Source Normalized Impact per Paper (SNIP)
4.731 - SCImago Journal Rank (SJR)
22 days to first decision for all manuscripts (Median)
28 days to first decision for reviewed manuscripts only (Median)
1,213,867 downloads (2022)
1,462 Altmetric mentions (2021)
Contact the Managing Editorial Team